Histone cluster 1 H2AE Inhibitors constitute a specialized class of chemical compounds engineered to selectively obstruct the activity of histone cluster 1, with a specific focus on the H2AE subtype. Histones are integral proteins involved in packaging DNA into nucleosomes, forming the structural foundation of chromatin. H2AE designates a variant of histone H2A, one of the core histones fundamental to nucleosome assembly. The H2A family of histones plays a central role in regulating gene expression and modulating chromatin structure. Inhibitors designed for Histone cluster 1 H2AE are crafted with precision to interact with specific regions of this histone variant, potentially affecting its binding to DNA and other proteins and, in turn, influencing chromatin dynamics.
The development of Histone cluster 1 H2AE Inhibitors demands a detailed understanding of the structural characteristics of histone H2AE and its specific role within chromatin organization. These inhibitors are meticulously designed for specificity, aiming to selectively bind to key regions of Histone cluster 1 H2AE and disrupt its normal functions. By employing these inhibitors in experimental contexts, researchers can investigate the consequences of inhibiting this particular histone variant, providing valuable insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H2AE, contributes significantly to advancing our understanding of epigenetic mechanisms, offering critical insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat inhibits histone deacetylase, impacting chromatin structure and potentially affecting the acetylation status of histones, including H2AE. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4 inhibits lysine demethylase, potentially influencing histone demethylation and the transcriptional regulation of genes, including H2AE. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EPZ-6438 targets EZH2, a histone methyltransferase, potentially impacting the methylation of histones and the expression of genes like H2AE. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat inhibits histone deacetylase, altering chromatin structure and potentially affecting the acetylation status of histones, including H2AE. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
UNC1999 targets the methyltransferase activity of histone methyltransferase, possibly impacting the methylation status and expression of H2AE. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a potent histone deacetylase inhibitor, influencing gene expression by maintaining acetylation levels on histones, including H2AE. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $90.00 $238.00 $300.00 | ||
GSK343 inhibits EZH2, potentially influencing histone methylation patterns and the transcriptional regulation of genes, including Histone cluster 1 H2AE. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
I-BET151 is a BET bromodomain inhibitor, disrupting interactions between bromodomain proteins and acetylated histones, potentially influencing gene expression, including H2AE. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
C646 is a selective inhibitor of histone acetyltransferase, modulating the acetylation of histones and influencing the expression of associated genes, including H2AE. | ||||||
UNC0638 | 1255580-76-7 | sc-397012 | 10 mg | $315.00 | ||
UNC0638 inhibits G9a, a histone methyltransferase, potentially influencing the methylation status of histones and the expression of genes, including H2AE. |